Americans grapple with prolonged testing woes amid Omicron surge -Breaking
[ad_1]
© Reuters. A line forms to get into a pop-up test site for coronavirus diseases (COVID-19), as soon as a person leaves. It is located in Bronx, New York City. January 12, 2022. REUTERS/Shannon Stapleton2/3
Maria Caspani & Brad Brooks
(Reuters.) Thousands of Americans are lining up to test for COVID-19. Kits for at-home testing are selling fast in pharmacies, drug stores and online. The holiday surge in demand has not subsided in the new year.
People across the nation were frustrated by the lack of testing, as the Omicron virus pushed infection to new heights. On Wednesday, the Biden administration announced plans to increase school test capacity.
Asa Wooten is a Lubbock pharmacist technician at Drug Emporium, 25 years old. She said that people are constantly coming in to get tested.
She said that about every fourth customer who walks into the shop is looking for a kit. “Within an hour of opening today, I received 10 inquiries from people about kits. And we get calls all the time.”
Wooten explained that unlike other West Texas retailers and pharmacies, Drug Emporium had not been stocked with testing kits for two weeks.
Within 20 minutes of receiving the final shipment, it was gone.
Test delays and testing shortages are having an adverse effect on many Americans’ lives, especially students and teachers whose attendance at school is dependent on their ability to take part in tests.
On Wednesday, President Joe Biden announced that new measures were being taken to ensure classes are open. These included doubling the testing capacity at schools and adding 10 million additional tests.
Biden made the announcement to expand testing access. It follows an announcement by Biden in December that 500,000,000 quick tests would be offered free of charge to Americans.
Biden has been accused by critics of failing to focus enough attention on testing for the control of Omicron hospitalizations and surging Omicron case numbers, amid increasing reports about acute test kit shortages in other parts of the country.
VACCINATIONS PIVOTING
A Reuters tally shows that the United States tops the list for the number of daily new infections. Accordingly to a Reuters report, it accounts for one third of all infections globally.
According to Reuters, Monday saw the nation break all global records by reporting 1.35 Million cases in a single morning.
Skippack Pharmacy near Philadelphia in Schwenksville has changed from providing vaccinations to offering testing, in order to respond to the surge of demand which began just before Christmas.
Mayank Amin, the owner, said during a telephone interview that he realized the company needed to expand. Mayank Amin spoke to Mayank Amin from the parking lot at a nearby baseball field. The independent pharmacy now has a testing facility.
Amin explained that while they still provide COVID-19 shots and book appointments for test, staff receive hundreds of calls every day from residents looking to order COVID-19 kit kits.
Shannon Raney, pharmacist at Doctor’s Orders Pharmacy in Star City Arkansas says that people come from all over Arkansas to use their testing supplies.
Family-owned and operated, the local business was able to meet rising demand through sharing its supplies with two nearby locations. According to her, she explained that while we currently have the in-facility tests and are short on the at-home testing kits, the other location has them so they could be sourced if necessary.
Due to an increase in demand, some laboratories have reported that testing is taking longer.
Quest Diagnostics (NYSE) is one of America’s largest commercial laboratories. It said that it has performed close to twice the COVID-19 testing it did in the third quarter last year. Results are returning on average within two to three business days. The company stated that most recipients of COVID-19 tests were receiving results within 24 hours.
Some labs have had problems with staffing.
Scott Becker (CEO of the Association of Public Health Laboratories, APHL) said that scientists at Laboratories (NYSE:), are becoming sick like everybody else. He represents 150 public health labs in each state.
Laboratory testing relies heavily on the staff, right from collection and transport of samples through to analysis and reporting results.
[ad_2]
